HOLLY ADAMS: Open Payments
NPI 1346564267 · PENSACOLA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$780 in 36 payments from 9 companies in 2025. Trend: 2023 $275 · 2024 $334 · 2025 $780
Food & beverage: $780
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $305 |
| Gilead Sciences, Inc. | 3 | $159 |
| Madrigal Pharmaceuticals | 3 | $66 |
| PFIZER INC. | 3 | $64 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $62 |
| Novo Nordisk Inc | 2 | $39 |
| Ardelyx, Inc. | 2 | $36 |
| Phathom Pharmaceuticals, Inc. | 2 | $30 |
| Regeneron Healthcare Solutions, Inc. | 1 | $20 |
Products named: Livdelzi, RINVOQ, LINZESS, SKYRIZI, REZDIFFRA, ENTYVIO, VELSIPITY, Wegovy.
Industry payments across FL — which companies pay providers there.
